What is the Exozymes Inc. stock price forecast?

Exozymes Inc. is currently trading at $7.10. View real-time AI analysis on Alpha Lenz.

What is Exozymes Inc. insider trading activity?

View the latest insider trading data for Exozymes Inc. on Alpha Lenz.

What is Exozymes Inc.'s P/E ratio?

View Exozymes Inc.'s valuation metrics on Alpha Lenz.

Exozymes Inc.

NASDAQ · EXOZ

$7.10-0.60(-7.79%)Pre-market

Ask about Exozymes Inc.'s future dividend policy...

Alpha Chat Insight

“Exozymes Inc.'s ROE is -132.6%. Explore profitability and growth together.”

Ask for details →

Company Overview

Exozymes Inc. operates in the biotechnology sector with a focus on developing enzyme-based products for industrial applications. The primary function of Exozymes Inc. is to leverage advanced enzymatic solutions to enhance processes across various industries, including pharmaceuticals, agriculture, and biofuels. Through its innovative approach, the company aims to improve efficiency, reduce environmental impact, and provide sustainable alternatives to traditional chemical processes. Exozymes Inc. plays a key role in the market by offering customizable enzyme solutions that cater to specific industrial needs, thereby driving technological advancements and promoting cleaner manufacturing practices. Its presence underscores the importance of biotechnology in revolutionizing conventional methods and addressing global environmental challenges.

CEOMr. Michael Heltzen

Websitehttps://www.exozymes.com

SectorHealthcare

IndustryBiotechnology

Employees31

Company Statistics

FY 2025

Profile

N/AMarket Cap

$0.00Revenue

0.00Shares Out

31Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-96.38%ROA

-132.56%ROE

-102.25%ROIC

Financial Health

$3.04MCash & Cash Equivalents

$-465.07KNet Debt

75.78%Debt/Equity

N/AInterest Cov